Use of Biosimilar Follicle-Stimulating Hormone in Asthenozoospermic Infertile Patients: A Multicentric Study

Use of Biosimilar Follicle-Stimulating Hormone in Asthenozoospermic Infertile Patients: A Multicentric Study

There is increasing data in favour of follicle-stimulating hormone (FSH) therapy in patients with oligo-asthenozoospermia and normal-range gonadotropins in order to increase sperm count and above all sperm motility. Some studies showed an improvement in DNA fragmentation and spontaneous pregnancy. R...

Full description

Bibliographic Details
Main Authors: Maurizio De Rocco Ponce, Carlo Foresta, Rocco Rago, Alessandro Dal Lago, Giancarlo Balercia, Aldo Eugenio Calogero, Sandro La Vignera, Ilaria Cosci, Andrea Di Nisio, Andrea Garolla
Format: Article
Language:English
Published: MDPI AG 2020-05-01
Series:Journal of Clinical Medicine
Subjects:
male infertility
follicle-stimulating hormone
biosimilar FSH
asthenozoospermia
sperm DNA fragmentation
Online Access:https://www.mdpi.com/2077-0383/9/5/1478

Internet

https://www.mdpi.com/2077-0383/9/5/1478

Similar Items